Varenicline solution nasal spray for dry eye disease in Chinese patients: a randomized phase 3 trialResearch in context

• Главные авторы: Lei Tian (Автор), Xiuming Jin (Автор), Jibing Wang (Автор), Yonggen Xu (Автор), Chengwei Lu (Автор), Shaozhen Zhao (Автор), Qian Zhu (Автор), Hong Dai (Автор), Hao Gu (Автор), Mingchang Zhang (Автор), Linnong Wang (Автор), Xiaohe Lu (Автор), Lixiao Ma (Автор), Lei Zhu (Автор), Qingyan Zeng (Автор), Hong Zhang (Автор), Yao Fu (Автор), Suxia Li (Автор), Liming Tao (Автор), Qian Ren (Автор), Faming Ding (Автор), Shenglin Zhang (Автор), Shaopin Zhu (Автор), Zhiping Li (Автор), Ying Jie (Автор)
• Формат: ‌
• Опубликовано: Elsevier, 2024-04-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Summary: Background: Dry eye disease has a high prevalence and exerts a significant negative effect on quality of life. In China, there are currently no available nasal sprays to promote natural tear production in patients with dry eye disease. We therefore evaluated the efficacy and safety of OC-01...